about
Tau Biology and Tau-Directed Therapies for Alzheimer's DiseaseNAP (davunetide) rescues neuronal dysfunction in a Drosophila model of tauopathy.Novel marker for the onset of frontotemporal dementia: early increase in activity-dependent neuroprotective protein (ADNP) in the face of Tau mutation.Peptides for therapy and diagnosis of Alzheimer's disease.MAPT as a predisposing gene for sporadic amyotrophic lateral sclerosis in the Chinese Han populationMedical management of frontotemporal dementias: the importance of the caregiver in symptom assessment and guidance of treatment strategiesMitochondrial dysfunction as a therapeutic target in progressive supranuclear palsy.Critical appraisal of the role of davunetide in the treatment of progressive supranuclear palsy.Frontotemporal lobar degeneration: epidemiology, pathology, diagnosis and management.D-NAP prophylactic treatment in the SOD mutant mouse model of amyotrophic lateral sclerosis: review of discovery and treatment of tauopathy.Management of frontotemporal dementia: targeting symptom management in such a heterogeneous disease requires a wide range of therapeutic options.ADNP: in search for molecular mechanisms and innovative therapeutic strategies for frontotemporal degeneration.Intracellular and extracellular microtubule associated protein tau as a therapeutic target in Alzheimer disease and other tauopathies.Stable mutated tau441 transfected SH-SY5Y cells as screening tool for Alzheimer's disease drug candidates.Tau pathology: predictive diagnostics, targeted preventive and personalized medicine and application of advanced research in medical practice.Proposal for Alzheimer's diagnosis using molecular buffer and bus networkTau Diagnostics and Clinical Studies.Nitrosylation of Vesicular Transporters in Brain of Amyloid Precursor Protein/Presenilin 1 Double Transgenic Mice.
P2860
Q28071398-3C929DBF-8FBD-480F-B26C-2281B7602C7BQ30540857-601E765D-007F-4772-B8D9-4240E729646DQ31149250-734935B8-454D-453B-9475-E52EBD63FB4EQ34124260-871FB510-EEB9-4C78-93FB-F911C10D9D7EQ34153586-BE22A2EF-412C-49B7-99F6-31DDFE43F312Q35523924-837E6963-8F64-4F91-86A3-20CDA43E41E4Q37906364-017D175D-7239-457F-8B48-E0624DF9039AQ37986036-14EA8CE1-F537-4406-8ABB-DAA0FC90C5AFQ38040822-82C676A6-3D6F-49CE-8A2A-F4A6F42A4BF5Q38041481-DAC2B8F0-448E-49D5-B8E6-AAE9DE77EFEBQ38391397-875B9434-97D8-4354-B9B0-52CAE683F3C5Q38636792-933FA6BD-9FCD-44DC-9D2D-4C34529FAEC4Q38664605-E044FBD3-D146-4F86-8870-15BD829C3486Q39393192-9884CEA8-9EA5-45A0-8F33-FC24505838C7Q41945501-EFEDC156-A407-4411-B210-647BCE7A98C7Q42055239-166EB95D-1F83-4149-B66F-7690015208F3Q47870437-B8F72590-0DF9-425A-ABFD-FD096C5D4ABEQ48409051-54D2EB6B-D8E0-4EF9-9FC9-7D640A538DFA
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Tau pathology and future therapeutics.
@en
Tau pathology and future therapeutics.
@nl
type
label
Tau pathology and future therapeutics.
@en
Tau pathology and future therapeutics.
@nl
prefLabel
Tau pathology and future therapeutics.
@en
Tau pathology and future therapeutics.
@nl
P1476
Tau pathology and future therapeutics.
@en
P2093
P304
P356
10.2174/156720510793611628
P577
2010-12-01T00:00:00Z